ABATACEPT IN MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL DISEASE-MODIFYING DRUGS: TREATMENT PERSISTENCE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS.

Munoz Reinoso, P.Garcia Hernandez, I.Hernandez-Cruz, B.Perez Venegas, J. J.2023-05-032023-05-032022-06-010003-4967http://hdl.handle.net/10668/20120enABATACEPT IN MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL DISEASE-MODIFYING DRUGS: TREATMENT PERSISTENCE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS.conference outputopen access10.1136/annrheumdis-2022-eular.46891468-2060https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1313.2.full.pdf850279005231